戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e, formed nuclear foci in cells treated with floxuridine.
2                                              Floxuridine (5-fluorodeoxyuridine, FdUrd), a U.S. Food a
3 nts 5-fluorouracil and 5-fluorodeoxyuridine (floxuridine), a 5-fluorouracil metabolite.
4  a CRISPR knockout screen in the presence of floxuridine, a chemotherapeutic agent that incorporates
5 um-labile prodrug of the nucleoside analogue floxuridine, a potent antineoplastic drug used in the cl
6 erial infusion pump (HAIP) chemotherapy with floxuridine aims to control the liver disease and improv
7 is through other mechanisms (hydroxyurea and floxuridine) also act synergistically with AZT.
8  the effectiveness of HAIP chemotherapy with floxuridine and concurrent systemic gem-cis in patients
9 ates with the phosphorylated 5-FU nucleoside Floxuridine and demonstrated their enhanced activity aga
10 six cycles of hepatic arterial infusion with floxuridine and dexamethasone plus intravenous fluoroura
11 re enrolled onto a phase I protocol with HAI floxuridine and dexamethasone plus systemic chemotherapy
12                     Up to six cycles of HAIP floxuridine and eight cycles of concurrent systemic gem-
13  combination of hepatic arterial infusion of floxuridine and intravenous fluorouracil improves the ou
14             Combining HAIP chemotherapy with floxuridine and systemic gem-cis in patients with unrese
15 ition of chemotherapy, such as capecitabine, floxuridine, and vinblastine, may increase the effective
16  its metabolite 5-fluorodeoxyuridine (FdUrd, floxuridine) are chemotherapy agents that are converted
17                            Patients received floxuridine at doses previously demonstrated as safe in
18  patients) or postoperative hepatic arterial floxuridine combined with intravenous continuous-infusio
19  dengue virus replication in the presence of floxuridine, consistent with thymidine-less stress trigg
20   CONCLUSION The combination of regional HAI floxuridine/dexamethasone and systemic oxaliplatin and i
21 transferase, METTL3, as required to overcome floxuridine-driven cytotoxicity.
22  ara-guanosine (AraG), gemcitabine (Ge), and floxuridine (FdU), to replace all natural nucleosides in
23 ) or combined with regional hepatic arterial floxuridine (FUDR) (n = 28).
24 followed by hepatic artery infusion (HAI) of floxuridine (FUDR) alternating with systemic fluorouraci
25 every 2 weeks concurrent with 2 weeks of HAI floxuridine (FUDR) and dexamethasone (Dex) every 28 days
26                           M1 contains both a floxuridine (FUDR) and protein phosphatase 2A (PP2A) inh
27 biliary toxicity may permit salvage HAI with floxuridine (FUDR) in patients whose liver tumors fail t
28 MTD) of systemic irinotecan (CPT-11) and HAI floxuridine (FUDR) plus dexamethasone (DEX) as combinati
29 efit of adjuvant hepatic arterial infusional floxuridine (HAI-FUDR) in addition to modern systemic ch
30 acil (5-FU) and 5-fluorodeoxyuridine (FdUrd, floxuridine) have activity in multiple tumors, and both
31 delivered concurrently with hepatic arterial floxuridine in 128 patients.
32 ylation facilitates UNG2-dependent repair of floxuridine-induced DNA lesions and promotes tumor cell
33 molecules, we observed that methotrexate and floxuridine inhibited dengue virus infections at low mic
34  control with orally treated Gemcitabine- or Floxuridine-nanogel conjugates.
35         Two patients (4%) did not start HAIP floxuridine; one patient died due to COVID-19, and one p
36 g patients with hepatic arterial infusion of floxuridine plus systemic fluorouracil after liver resec
37  focal liver irradiation with hepatic artery floxuridine prolongs survival in patients with unresecta
38 otrexate and by thymidine in the presence of floxuridine, suggesting an unexpected role for thymidine
39 n cancer cell line that is hypersensitive to floxuridine, we show that GSK-3 phosphorylation facilita
40 re highly sensitive to both methotrexate and floxuridine, whereas other RNA viruses (Sindbis virus an
41 On univariate analysis, receipt of HAI-FUDR (floxuridine) within 1 year of IHP was the only factor as
42 e radiation with concurrent hepatic arterial floxuridine would improve survival in patients with unre